Antithrombotic Strategies After Complex Percutaneous Coronary Intervention

Area of Science:

• Interventional Cardiology
• Cardiovascular Pharmacology

Background:

• Complex percutaneous coronary intervention (PCI) is increasing due to aging populations and comorbidities.
• Complex PCI involves challenging lesions like left main disease, chronic total occlusions, and severe calcification.
• Antithrombotic therapy is vital post-PCI but poses a high bleeding risk in these patients.

Purpose of the Study:

• To review current evidence and guidelines on antithrombotic therapy after complex PCI.
• To discuss balancing ischemic and bleeding risks in patients undergoing complex PCI.
• To provide clinical considerations for antithrombotic management post-complex PCI.

Main Methods:

• Literature review of contemporary evidence.
• Synthesis of current guideline recommendations.
• Analysis of clinical considerations for antithrombotic therapy.

Main Results:

• Complex PCI is a growing area of coronary revascularization.
• Balancing ischemic and bleeding risks is paramount in antithrombotic selection.
• Guideline recommendations shift focus from procedural complexity to risk stratification.

Conclusions:

• Antithrombotic therapy requires careful management after complex PCI.
• Risk-benefit assessment is essential for tailoring antithrombotic regimens.
• Contemporary approaches prioritize individualized patient care over solely procedural factors.